Profile
Home  /   Staff  /   Researcher Profiles  /  Dr Christopher Scarlett  /  Research Funding

Dr Christopher Scarlett

Work Phone (02) 4348 4680
Email
Office SO E1.46, Science Offices

Funding

Summary

Number of grants 10
Total funding $2,583,365

For project grants received where the lead institution is other than the University of Newcastle, details are shown in italics.

Seeking students for this project. - Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2012 (5 grants)

The therapeutic potential of targeting S100A2 calcium-binding protein in pancreatic cancer$177,450
Funding Body: Cure Cancer Australia Foundation

Novel Targeted Therapies for Pancreatic Cancer$149,877
Funding Body: Cancer Institute NSW

Establishment of a pancreatic cancer research program for screening the activity and efficacy of natural bioactive compounds$74,048
Funding Body: Ramaciotti Foundations

The therapeutic potential of targeting S100A2 calcium-binding protein in pancreatic cancer$44,363
Funding Body: Cancer Australia

Project support to develop pancreatic cancer research within the School$5,000
Funding Body: University of Newcastle

2011 (1 grants)

Targeting histone deacetylases for the therapy of Myc-induced malignancies$344,208
Funding Body: NHMRC (National Health & Medical Research Council)

2010 (2 grants)

Novel Targeted Therapies for Pancreatic Cancer$599,681
Funding Body: Cancer Institute NSW

Targeting Myc onco-protein degradation for the treatment of Myc-induced malignancies$319,500
Funding Body: Cancer Council NSW

2009 (1 grants)

Continuing infrastructure support for the ACRF Genomics Facility$330,000
Funding Body: Cancer Institute NSW

2007 (1 grants)

Adult Haematopoietic Stem Cells in The Evolution of Pancreatic Cancer$539,238
Funding Body: Cancer Institute NSW